CN106461666B - 检测癌症的方法 - Google Patents

检测癌症的方法 Download PDF

Info

Publication number
CN106461666B
CN106461666B CN201580008934.2A CN201580008934A CN106461666B CN 106461666 B CN106461666 B CN 106461666B CN 201580008934 A CN201580008934 A CN 201580008934A CN 106461666 B CN106461666 B CN 106461666B
Authority
CN
China
Prior art keywords
cells
antibody
telomerase
cancer
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580008934.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN106461666A (zh
Inventor
M·拉拉
F·图拉蒂
S·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sienna Cancer Diagnostics Ltd
Original Assignee
Sienna Cancer Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014900494A external-priority patent/AU2014900494A0/en
Application filed by Sienna Cancer Diagnostics Ltd filed Critical Sienna Cancer Diagnostics Ltd
Publication of CN106461666A publication Critical patent/CN106461666A/zh
Application granted granted Critical
Publication of CN106461666B publication Critical patent/CN106461666B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
    • G01N2333/9128—RNA-directed DNA polymerases, e.g. RT (2.7.7.49)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
CN201580008934.2A 2014-02-17 2015-02-17 检测癌症的方法 Active CN106461666B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014900494 2014-02-17
AU2014900494A AU2014900494A0 (en) 2014-02-17 Methods of detecting cancer
PCT/AU2015/050060 WO2015120523A1 (en) 2014-02-17 2015-02-17 Method of detecting cancer

Publications (2)

Publication Number Publication Date
CN106461666A CN106461666A (zh) 2017-02-22
CN106461666B true CN106461666B (zh) 2020-11-03

Family

ID=53799455

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580008934.2A Active CN106461666B (zh) 2014-02-17 2015-02-17 检测癌症的方法

Country Status (9)

Country Link
US (2) US10338072B2 (https=)
EP (1) EP3108256B1 (https=)
JP (1) JP6685229B2 (https=)
CN (1) CN106461666B (https=)
AU (1) AU2015218188B2 (https=)
DK (1) DK3108256T3 (https=)
ES (1) ES2818089T3 (https=)
IL (1) IL247270B (https=)
WO (1) WO2015120523A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3108256T3 (da) 2014-02-17 2020-09-21 Sienna Cancer Diagnostics Ltd Fremgangsmåde til detektering af cancer
US20180238891A1 (en) * 2015-08-19 2018-08-23 Sienna Cancer Diagnostics Ltd Cancer Detection Method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09262100A (ja) * 1996-03-27 1997-10-07 Mount Sinai School Medicine City Univ New York テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法
NZ528205A (en) * 2001-03-12 2006-09-29 Monogen Inc Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
ES2360954T3 (es) 2005-02-18 2011-06-10 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procedimientos para detectar la evolución de la displasia de cuello uterino de bajo grado.
US20090142259A1 (en) * 2006-05-12 2009-06-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
WO2009075803A2 (en) 2007-12-05 2009-06-18 The Johns Hopkins University Alternative splice variant patterns of human telomerase reverse transcriptase (htert) in thyroid tumors to distinguish benign from malignant
DK3108256T3 (da) 2014-02-17 2020-09-21 Sienna Cancer Diagnostics Ltd Fremgangsmåde til detektering af cancer
US20180238891A1 (en) 2015-08-19 2018-08-23 Sienna Cancer Diagnostics Ltd Cancer Detection Method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer;Yasushi Hashimoto et al;《Surgery》;20080131;第143卷(第1期);摘要，114页左栏，120页左栏第1段 *
Urine Telomerase: An Important Marker in the Diagnosis of Bladder Cancer;Maria Aurora Sanchini et al;《Neoplasia》;20040630;第6卷(第3期);摘要，table 2，235页右栏，236页右栏， 238页左栏 *

Also Published As

Publication number Publication date
ES2818089T3 (es) 2021-04-09
US10338072B2 (en) 2019-07-02
DK3108256T3 (da) 2020-09-21
IL247270B (en) 2019-12-31
IL247270A0 (en) 2016-09-29
WO2015120523A1 (en) 2015-08-20
EP3108256A1 (en) 2016-12-28
AU2015218188B2 (en) 2020-11-05
US20170176438A1 (en) 2017-06-22
JP6685229B2 (ja) 2020-04-22
JP2017505911A (ja) 2017-02-23
CN106461666A (zh) 2017-02-22
AU2015218188A1 (en) 2016-09-15
US11391738B2 (en) 2022-07-19
EP3108256A4 (en) 2017-10-04
US20200049715A1 (en) 2020-02-13
EP3108256B1 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
US12366574B2 (en) Keratin 17 as a biomarker for bladder cancer
US9075065B2 (en) Prostate cancer biomarker
US20220381785A1 (en) Cancer Detection Method
Chen et al. Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma
CA2823460A1 (en) Diagnostic method
US11391738B2 (en) Method of detecting cancer
US11054426B2 (en) Diagnostic method
Tiguert et al. New diagnostic and prognostic tools in bladder cancer
JP5574522B2 (ja) 癌マーカー及び癌細胞の検査方法
Pavlova et al. Evaluation of new immunohistochemical approaches for the study of kidney tumors in geriatric
LOKESHWAR et al. Cytology and tumor markers: Tumor markers beyond cytology

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant